EMEA Denies Biosimilar To Roche’s Interferon Alfa-2a
This article was originally published in The Pink Sheet Daily
Executive Summary
BioPartners’ Alpheon – a generic version of Roferon-A – has “major quality concerns,” the European Medicines Agency finds.